#USA #Boston #Patient Safety #ArisGlobal #EU AI Pact

ArisGlobal Takes a Stand on Ethical AI by Joining EU AI Pact

In a significant move highlighting its dedication to responsible artificial intelligence (AI) practices, ArisGlobal has officially signed the EU AI Pact. This initiative, aimed at promoting ethical AI development and implementation, aligns with the company’s mission of maximizing societal benefits, particularly in the realm of patient safety.

ArisGlobal, a leader in the life sciences sector and creator of the advanced LifeSphere® platform, believes that AI can and should provide value to society. The EU AI Pact serves as a voluntary framework intended to prepare organizations for the upcoming EU AI Regulation—an unprecedented measure in global regulatory landscape concerning AI.

By joining the pact, ArisGlobal publicly reaffirms its commitment to uphold the highest standards in AI governance, ethics, and responsibility. The signing emphasizes the company's resolve to ensure that its clients in the biopharmaceutical field can trust in the benefits AI offers, such as new and improved insights into patient safety.

Promoting Responsible AI Practices

The EU AI Pact not only represents a commitment but also sets a clear path for the implementation of a robust AI governance strategy within participating organizations. ArisGlobal’s participation indicates that it is taking important steps to map out high-risk AI systems, identifying those likely to be classified as high-risk under the forthcoming legislation.

Additionally, the pact underscores the importance of enhancing staff knowledge and awareness about AI, fostering an environment where ethical practices are paramount in AI development and deployment.

Jason Bryant, the Vice President of Product Management for AI Data at ArisGlobal, stated, "We believe that AI should benefit society, which is only possible with ethical AI practices. Our commitment to responsible AI is underscored not only by our industry leadership but also through the application of technology to gain advanced insights that empower our clients to make better decisions contributing to patient safety."

Commitment to Transparency and Improvement

ArisGlobal intends to keep stakeholders informed about its progress in maintaining its core promises and the additional initiatives it undertakes to promote best practices within the industry. This transparent approach will ensure that their advancements in responsible AI are as clear to the public as their commitment to ethical practices.

As an innovative technology provider at the forefront of the life sciences industry, ArisGlobal is on a mission to transform how the world's leading biopharmaceutical companies drive breakthrough innovations and bring new products to market. With its headquarters based in the United States and branches across Europe, India, Japan, and China, ArisGlobal is positioned as a global leader in ethical AI application.

Follow ArisGlobal on LinkedIn or visit arisglobal.com for more updates on their initiatives and commitment to shaping a responsible AI future.